Verbatim response from Perplexity
You should consider switching to Zepbound or Saxenda, as both are FDA-approved injectable alternatives to Wegovy with potentially better insurance coverage or lower cash prices.
Zepbound (tirzepatide) is often the most cost-effective option:
- It has a list price of $1,086.37 per month, which is lower than Wegovy [5].
- For cash-paying patients without insurance, LillyDirect offers Zepbound vials at $399/month (2.5 mg) or $549/month (5 mg), making it significantly more affordable than Wegovy's cash price [5][8].
- It is a weekly injection that may lead to greater average weight loss than Wegovy in head-to-head trials [6].
Saxenda (liraglutide) is another strong alternative if your plan covers it:
- It is an injectable GLP-1 receptor agonist in the same class as Wegovy [2].
- If price is an important consideration and your insurance plan covers Saxenda instead of Wegovy, it may be your preferred option [2].
- Note that Saxenda is a daily injection, whereas Wegovy and Zepbound are weekly [3].
Other options to discuss with your provider:
- Phentermine: Often the most affordable prescription option (as little as $10) and covered by nearly all insurance plans [6][8].
- Ozempic: Contains the same active ingredient (semaglutide) as Wegovy but is prescribed for type 2 diabetes; it may be used off-label for weight loss if you have a diabetes diagnosis [1][7].
- The Wegovy pill: The newly approved oral version of Wegovy may be an alternative if the injection is unavailable or too costly [3].
Important Next Step: Before switching, consult your healthcare provider to safely change medications and determine which alternative is best for your specific health needs and insurance coverage [1]. You can also check your insurance formulary to see if Zepbound or Saxenda is covered at a lower tier than Wegovy.